Charles McWherter
President and Chief Scientific Officer
United StatesResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Charles McWherter is the President and Chief Scientific Officer at CymaBay Therapeutics in the United States. His research primarily focuses on the development and efficacy of Seladelpar in treating primary biliary cholangitis and nonalcoholic steatohepatitis. Recent publications highlight the effects of Seladelpar on bile acid synthesis, interleukin-31 levels, and overall liver health. His work aims to enhance therapeutic strategies for liver diseases through innovative treatments.
Articles (9)
Year:
2025
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2021
Collaborators (8)
Christopher L. Bowlus
-
Aparna Goel
Assistant Clinical Professor
Stanford University School of Medicine
Gideon M. Hirschfield
-
Andreas Kremer
University of Zurich
Stephen A. Harrison
University of Oxford
David Sheridan
Associate Professor (Senior Lecturer)
Plymouth University Peninsula Schools of Medicine and Dentistry
Cynthia Levy
Professor of Medicine
University of Miami
John Vierling
Professor of Medicine and Surgery (tenured); Chief of Hepatology
Baylor College of Medicine
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.